Status:

COMPLETED

A Randomized Study of Superiority of POSToperative Pharmaceutical Support on Patients' Knowledge of Their IMPlant

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Joint Prosthesis

Breast Implants

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Recently joint and breast prostheses were placed under special post-marketing surveillance in order to prevent new occurrence of serious incidents by agency for medicines and health products safety. F...

Eligibility Criteria

Inclusion

  • Patient aged 18 or over
  • Patient hospitalized following the scheduled placement of one of the following prostheses: three-compartment knee prostheses or total hip prosthesis or breast implant
  • French-speaking or non-French-speaking patient accompanied by a French-speaking support person
  • Patient having received complete information and having signed a free and informed consent for the research
  • Patient affiliated to a social security scheme (beneficiary or entitled)

Exclusion

  • Patient having been operated on for the installation of an orthopedic prosthesis not programmed within the framework of a trauma emergency.
  • Patient suffering from post-operative confusional syndrome;
  • Non-French speaking patient unaccompanied or accompanied by a non-French speaking support person
  • Patient on state medical aid
  • Persons referred to in articles L1121-5, 6 and 8 of the public health code (corresponds to protected persons): pregnant woman, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection measure, hospitalized for psychiatric disorder.
  • Patient who has already had postoperative pharmaceutical support for the placement of the same type of prosthesis on the contralateral limb
  • Patient suffering from a known cognitive or memory disorder.
  • Patient expressly refusing to participate in the telephone interview

Key Trial Info

Start Date :

May 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2021

Estimated Enrollment :

236 Patients enrolled

Trial Details

Trial ID

NCT04302233

Start Date

May 20 2020

End Date

November 1 2021

Last Update

February 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, France, 94010

A Randomized Study of Superiority of POSToperative Pharmaceutical Support on Patients' Knowledge of Their IMPlant | DecenTrialz